Forecast Period | 2024-2028 |
Market Size (2022) | USD 10.83 Billion |
CAGR (2023-2028) | 6.22% |
Fastest Growing Segment | Portable |
Largest Market | North America |
Market Overview
Key Market Drivers
Surge In the Latest Oxygen Therapy Solutions
Increase in Tobacco Smoking
Rising Prevalence of Respiratory Diseases
Technological Advancement in Oxygen Therapy
Key Market Challenges
Stringent Regulatory Guidelines
Frequent Adverse Effects
Key Market Trends
Technology Advancements in Therapeutic Equipment
Advanced Portable Oxygen Solutions
Segmental Insights
Mobility Insights
Based on the mobility segment, the stationary oxygen therapy equipment devices is projected to dominate the market in terms of portability. This is primarily due to the fact that a significant number of patients receiving treatment are confined to beds, thus making the fixed oxygen therapy equipment market the key driver and contributor to maximum market revenue throughout the projection period.
The expansion of this category can be attributed to several factors, including a rising population base, favourable reimbursement policies, and a low mobility profile of patients. As a result, there is an increased demand for long-term oxygen therapy (LTOT) equipment in residential settings, which is expected to further boost the overall demand for oxygen therapy equipment over the projected period. The utilization of LTOT equipment in residential settings not only provides enhanced convenience and comfort for patients but also contributes to the overall improvement in their quality of life.
Application Insights
Based on the Application, the market is bifurcated into Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Pneumonia, COVID-19, and others. Among these, the Chronic Obstructive Pulmonary Disorder (COPD) segment dominates the market with the largest share, owing to the increasing prevalence of COPD worldwide. According to estimates by the World Health Organization (WHO), approximately 65 million individuals are currently suffering from COPD, making it the fifth-leading cause of death globally. This alarming statistic highlights the urgent need for effective COPD therapy and creates a significant clinical demand in the market, which in turn contributes to the growth of companies operating in this domain. With the rising prevalence of COPD, there is an increasing focus on developing innovative treatment solutions to address this chronic respiratory disorder and improve the quality of life for affected individuals.
Regional Insights
Recent Developments
- In July 2021 -Belluscura (BELL) announced the signing of its first contract and thirddistribution agreement with a producer of durable medical equipment for itsline of portable oxygen concentrators, X-PLO2RTM. Durable medical equipment(DME) is available online and at multiple retail locations across variousstates. The X-PLO2RTM portable oxygen concentrator, expected to be deliveredwithin 90 days, has already received orders from the third distributor.
- In June 2020,Vincent Medical Holdings Limited, a global supplier of respiratory medicaldevices, announced a supply agreement with TAMER Healthcare for the provisionof InspiredTM O2FLO High Flow Respiratory Humidifier ("O2FLO") andassociated disposables to the Kingdom of Saudi Arabia.
- In April 2019,Inogen, Inc. launched the Inogen One G5, a lightweight and portable oxygenconcentrator.
Key Market Players
- Allied Healthcare Products, Inc.
- CAIRE Inc.
- DeVilbiss Healthcare
- Fisher & Paykel Healthcare Limited
- Inogen Inc.
- Invacare Corporation
- Koninklijke Philips N.V.,
- Smith’s Medical, Inc.
- Taiyo Nippon Sanso Corporation
- Linde Healthcare
By Product Type | By Mobility | By Application | By End User | By Region |
| - Oxygen Source Equipment
- Oxygen Delivery Devices
| | - COPD
- Lung Cancer
- Pneumonia
- COVID-19
- Others
| - Hospitals & Clinics
- Ambulatory Care Centers
- Homecare
- Others
| - North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
| |
| | | | | | | |